Table 5.

Pathologic features, tumor markers assessment and mutation screening of male breast cancer patients

Patient	Age	Side	Stage	Grade	Axillary Lymph Node Involvement	ER	PR	HER-2	CK5/6	BRCA1	BRCA2
01	44	Left	І	Ш	+	+	+	_	_	_	_
02	72	Left	Шb	Ц	_	_	_	_	_	_	+
03	48	Left	Цa	Ц	_	+	+	_	_	_	_
04	57	Right	І	Ш	+	+	+	_	_	_	_
05	49	Left	Цa	Ц	+	+	+	_	_	+	_
06	44	Left	І	Ц	Not available	+	+	_	_	_	_
07	52	Right	Ц	Ц	Not available	+	+	_	_	_	_
*08	38	Right	Ц	Ц	_	+	+	_	_	_	_
09	65	Right	І	Ц	_	+	+	_	_	_	_
10	57	Right	І	Ш	_	_	_	_	_	_	_

^*The patient has a family history of breast cancer.